Silverarc Capital Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$24.92 - $30.02 $40,295 - $48,542
-1,617 Reduced 2.0%
79,194 $1.99 Million
Q4 2023

Feb 14, 2024
SELL
$27.14 - $34.93 $795,283 - $1.02 Million
-29,303 Reduced 26.61%
80,811 $2.39 Million
Q3 2023

Nov 13, 2023
BUY
$24.63 - $32.85 $92,091 - $122,826
3,739 Added 3.51%
110,114 $3.48 Million
Q2 2023

Aug 14, 2023
BUY
$23.51 - $30.09 $10,250 - $13,119
436 Added 0.41%
106,375 $2.75 Million
Q1 2023

May 15, 2023
BUY
$19.19 - $24.1 $2.03 Million - $2.55 Million
105,939 New
105,939 $2.54 Million

Others Institutions Holding MIRM

# of Institutions
190
Shares Held
54M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.64B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email